
When administered to humans, metamizol rapidly undergoes predominantly nonenzymatic biotransformation, yielding a vast number of active and later inactive metabolites. The biotransformational pathways and the clinical significance of the metabolites are discussed in the light of their individual pharmacokinetics.
Male, Metabolic Clearance Rate, Dipyrone, Acetylation, Humans, Female, Aminopyrine, Biotransformation, Chromatography, High Pressure Liquid, Protein Binding
Male, Metabolic Clearance Rate, Dipyrone, Acetylation, Humans, Female, Aminopyrine, Biotransformation, Chromatography, High Pressure Liquid, Protein Binding
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
